Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Operating Expenses (2019 - 2025)

Historic Operating Expenses for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $114.3 million.

  • Harmony Biosciences Holdings' Operating Expenses rose 4018.15% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $416.1 million, marking a year-over-year increase of 1525.46%. This contributed to the annual value of $367.1 million for FY2024, which is 3658.97% up from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Operating Expenses stood at $114.3 million for Q3 2025, which was up 4018.15% from $114.2 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Operating Expenses high stood at $119.3 million for Q2 2024, and its period low was $34.7 million during Q1 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median Operating Expenses value was $63.5 million (recorded in 2023), while the average stood at $71.4 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Operating Expenses crashed by 2293.13% in 2023, and later surged by 9149.68% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Operating Expenses (Quarter) stood at $44.8 million in 2021, then rose by 20.21% to $53.8 million in 2022, then surged by 58.08% to $85.1 million in 2023, then increased by 7.13% to $91.1 million in 2024, then grew by 25.44% to $114.3 million in 2025.
  • Its last three reported values are $114.3 million in Q3 2025, $114.2 million for Q2 2025, and $96.5 million during Q1 2025.